Lilly announces plans to build $5 billion manufacturing facility in Virginia

Core Points - Eli Lilly and Company plans to build a $5 billion manufacturing facility in Goochland County, Virginia, focusing on active pharmaceutical ingredients (API) for cancer and autoimmune therapies [1][2] - The facility will create 2,450 high-wage jobs, including 650 manufacturing positions and 1,800 construction jobs, contributing significantly to the local economy [4][5] - This site is the first of four new U.S. manufacturing locations Lilly intends to announce this year as part of a broader $50 billion capital expansion commitment since 2020 [2][9] Company Commitment - The investment in Virginia highlights Lilly's commitment to U.S. innovation and manufacturing, aiming to strengthen the domestic supply chain and enhance the delivery of medicines [4][6] - Lilly plans to utilize advanced technologies such as machine learning and AI at the new facility to ensure efficient and safe production processes [6][8] - The company emphasizes sustainability and community engagement, planning to partner with local universities and support educational initiatives [6][8] Economic Impact - For every dollar invested in the Virginia facility, it is expected that up to four dollars will be generated in local economic activity [5] - Each manufacturing job created is projected to support multiple positions in related industries, such as supply chain and logistics [5] - The facility is anticipated to significantly benefit the local economy and strengthen Virginia's position in the pharmaceutical industry [6][8]